Skip to main content

Table 3 Characteristics related to the mortality of patients with heart failure at New York Heart Association IV functional class according to their place of residence

From: Relationship between the place of living and mortality in patients with advanced heart failure

 

Overall

Urban

Rural

Alive

N = 556

Dead

N = 592

P value

Alive

N = 484

Dead

N = 488

P value

Alive

N = 72

Dead

N = 104

P value

Age

79.7 (9.3)

83.3 (8.0)

< 0.001

79.7 (9.5)

83.0 (7.9)

< 0.001

79.9 (8.5)

85.1 (8.0)

< 0.001

Body Mass Index a

31.5 (6.7)

28.9 (6.4)

< 0.001

31.7 (6.8)

29.1 (6.5)

< 0.001

31.0 (5.7)

28.0 (5.6)

0.004

Smoker

22 (4)

19 (3)

0.698

20 (4)

16 (3)

0.532

2 (3)

3 (3)

0.801

Comorbidity

 Diabetes

234 (42)

251 (42)

0.971

204 (42)

218 (45)

0.466

30 (42)

33 (32)

0.233

 Coronary heart disease

178 (32)

197 (33)

0.782

160 (33)

166 (34)

0.804

18 (25)

31 (30)

0.597

 Stroke

78 (14)

85 (14)

0.854

74 (15)

67 (14)

0.549

4 (5)

18 (17)

0.037

 Chronic kidney disease

162 (29)

229 (39)

< 0.001

146 (30)

185 (38)

0.013

16 (22)

44 (42)

0.009

 Chronic Obstructive Pulmonary disease

170 (31)

208 (35)

0.089

150 (31)

172 (35)

0.180

20 (28)

36 (35)

0.428

 Atrial fibrillation

254 (46)

282 (48)

0.707

224 (46)

229 (47)

0.891

30 (42)

53 (51)

0.289

 Cancer

81 (15)

135 (23)

< 0.001

70 (15)

113 (23)

0.001

11 (15)

22 (21)

0.432

 Hypertension

449 (81)

460 (77)

0.218

388 (80)

386 (79)

0.739

61 (85)

74 (71)

0.056

Clinical Variables

 Heart ratea

76.6 (15.2)

76.8 (14.0)

0.735

76.5 (14.7)

77.3 (14.2)

0.413

77.5 (18.8)

75.0 (13.4)

0.329

 Systolic blood pressure (mm Hg)a

127.7 (18.4)

123.3 (18.5)

< 0.001

128 (18.3)

124 (18.9)

0.002

128 (19.5)

121 (17.1)

0.008

 Diastolic blood pressure (mm Hg)a

69.5 (10.7)

66.7 (10.3)

< 0.001

69.6 (10.7)

67.0 (10.3)

< 0.001

69.2 (10.7)

65.7 (10.4)

0.031

 Potassium (mEq/dL)a

4.5 (0.5)

4.6 (0.6)

0.033

4.5 (0.5)

4.5 (0.6)

0.082

4.5 (0.4)

4.6 (0.5)

0.246

 Sodium (mEq/dL)a

140.8 (3.5)

140.5 (3.9)

0.060

141 (3.4)

141 (3.8)

0.180

141 (3.8)

140 (3.9)

0.455

 Creatininea

1.2 (0.6)

1.4 (0.8)

< 0.001

1.2 (0.6)

1.5 (0.8)

< 0.001

1.2 (0.5)

1.3 (0.6)

0.171

 Haemoglobin (gr/dL)a

12.3 (1.7)

11.9 (1.8)

< 0.001

12.3 (1.8)

11.9 (1.8)

< 0.001

12.5 (1.5)

11.9 (1.8)

0.013

 Barthel Index imputeda

59.8 (27.8)

54.4 (28.6)

< 0.001

59.7 (27.3)

54.9 (28.3)

0.007

60.8 (31.6)

52.5 (30.5)

0.083

 Charlson Indexa

3.2 (1.6)

3.8 (1.8)

< 0.001

3.3 (1.6)

3.8 (1.8)

< 0.001

2.9 (1.2)

3.5 (1.6)

0.005

Medication

 Beta-blockers

271 (49)

246 (42)

0.011

235 (49)

213 (44)

0.142

36 (50)

33 (32)

0.022

 ACEi or ARBb

397 (71)

361 (61)

< 0.001

339 (70)

300 (62)

0.006

58 (81)

61 (59)

0.004

 MRAc

145 (26)

159 (27)

0.883

130 (27)

133 (27)

0.947

15 (21)

26 (25)

0.644

 Loop diuretics

479 (86)

536 (91)

0.083

416 (86)

443 (91)

0.025

63 (88)

93 (89)

0.878

Social Variables

 Living alone

164 (29)

179 (30)

0.988

146 (30)

155 (32)

0.639

18 (25)

24 (23)

0.909

 Inadequate housing conditions

220 (40)

287 (48)

0.002

187 (39)

237 (49)

0.002

33 (46)

50 (48)

0.889

  1. aMean (Standard deviation); bACEi angiotensin converting enzyme inhibitors, ARB Angiotensin II a receptor blockers; cMRA mineralocorticoid receptor antagonists